179 related articles for article (PubMed ID: 28212582)
1. The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis.
Cheng J; Zeng Z; Ye Q; Zhang Y; Yan R; Liang C; Wang J; Li M; Yi M
Oncotarget; 2017 Apr; 8(15):24327-24336. PubMed ID: 28212582
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer: a systematic review and meta-analysis.
Cao W; Yao X; Cen D; Zhi Y; Zhu N; Xu L
World J Surg Oncol; 2019 Aug; 17(1):132. PubMed ID: 31375109
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Pretreatment Thrombocytosis in Cervical Cancer Patients Treated With Definitive Radiotherapy.
Kawano M; Mabuchi S; Matsumoto Y; Sasano T; Takahashi R; Kuroda H; Kozasa K; Isohashi F; Ogawa K; Kimura T
Int J Gynecol Cancer; 2015 Nov; 25(9):1656-62. PubMed ID: 26332391
[TBL] [Abstract][Full Text] [Related]
4. The Significance of Pretreatment Thrombocytosis and Its Association With Neutrophilia in Patients With Surgically Treated Endometrial Cancer.
Takahashi R; Mabuchi S; Kuroda H; Kozasa K; Yokoi E; Matsumoto Y; Kimura T
Int J Gynecol Cancer; 2017 Sep; 27(7):1399-1407. PubMed ID: 28604454
[TBL] [Abstract][Full Text] [Related]
5. Poor Prognosis Significance of Pretreatment Thrombocytosis in Patients with Colorectal Cancer: a Meta-Analysis.
Zhao JM; Wang YH; Yao N; Wei KK; Jiang L; Hanif S; Wang ZX
Asian Pac J Cancer Prev; 2016; 17(9):4295-4300. PubMed ID: 27797233
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of pretreatment thrombocytosis in gastric cancer: A systematic review and meta-analysis.
Yang C; Jiang H; Huang S; Hong H; Huang X; Wang X; Liao W; Wang X; Chen X; Jiang L
Medicine (Baltimore); 2018 Aug; 97(31):e11763. PubMed ID: 30075601
[TBL] [Abstract][Full Text] [Related]
7. The pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: a systematic review and meta-analysis.
Wang YH; Deng SJ; Yang YD; Yao N; Zhao JM; Min GT; Wang J; Xu TF; Zhao PY; Wang HP; Chen W
Biomark Med; 2017 Feb; 11(2):195-210. PubMed ID: 28097884
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review.
Wu J; Chen M; Liang C; Su W
Oncotarget; 2017 Feb; 8(8):13400-13412. PubMed ID: 28077792
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of pretreatment thrombocytosis in patients with endometrial cancer: a meta-analysis.
Bai YY; Du L; Jing L; Tian T; Liang X; Jiao M; Nan KJ; Guo H; Ruan ZP
Cancer Manag Res; 2019; 11():4283-4295. PubMed ID: 31190994
[No Abstract] [Full Text] [Related]
10. Prognostic significance of pretreatment plasma fibrinogen and platelet levels in patients with early-stage cervical cancer.
Zhao K; Deng H; Qin Y; Liao W; Liang W
Gynecol Obstet Invest; 2015; 79(1):25-33. PubMed ID: 25278089
[TBL] [Abstract][Full Text] [Related]
11. Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.
Ye Q; Cheng J; Ye M; Liu D; Zhang Y
J Gynecol Oncol; 2019 Jan; 30(1):e5. PubMed ID: 30479089
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytosis as a prognostic factor in women with cervical cancer.
Lopes A; Daras V; Cross PA; Robertson G; Beynon G; Monaghan JM
Cancer; 1994 Jul; 74(1):90-2. PubMed ID: 8004588
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment thrombocytosis predict poor prognosis in patients with endometrial carcinoma: a systematic review and meta-analysis.
Nie D; Yang E; Li Z
BMC Cancer; 2019 Jan; 19(1):73. PubMed ID: 30646853
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer.
Onal C; Guler OC; Yildirim BA
Int J Gynecol Cancer; 2016 Jul; 26(6):1169-75. PubMed ID: 27206286
[TBL] [Abstract][Full Text] [Related]
15. The pretreatment thrombocytosis as one of prognostic factors for gastric cancer: A systematic review and meta-analysis.
Wang YH; Kang JK; Zhi YF; Zhang Y; Wang ZQ; Zhou Q; Niu WY; Ma MJ
Int J Surg; 2018 May; 53():304-311. PubMed ID: 29654963
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis.
Zhang J; Liu J; Zhu C; He J; Chen J; Liang Y; Yang F; Wu X; Ma X
Oncotarget; 2017 Apr; 8(15):24797-24803. PubMed ID: 28177889
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological effect of the prognostic nutritional index (PNI) in patients with cervical cancer: a meta-analysis.
Niu Z; Yan B
Ann Med; 2023; 55(2):2288705. PubMed ID: 38039954
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment thrombocytosis predicts prognosis of endometrial cancer: A meta-analysis of 11 studies.
Ye Q; Wu Z; Xia T; Liu D; Yang Y; Tang H
Exp Ther Med; 2020 Jan; 19(1):359-366. PubMed ID: 31853312
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E
Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984
[TBL] [Abstract][Full Text] [Related]
20. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.
Rodriguez GC; Clarke-Pearson DL; Soper JT; Berchuck A; Synan I; Dodge RK
Obstet Gynecol; 1994 Mar; 83(3):445-8. PubMed ID: 8127540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
